Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO · NASDAQ Global Market
+$0.05 today
Vol 0.31M · Avg 0.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+28.71%
Period High
$5.35
Period Low
$2.35
Latest
$3.99
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$329.69M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$291.72M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$212.26M
Inventiva S.A.
NASDAQ:IVA
$183.84M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$170.51M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$156.97M
Protara Therapeutics, Inc.
NASDAQ:TARA
$155.32M
Invivyd, Inc.
NASDAQ:IVVD
$130.11M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.66M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$116.96M
What is the latest OBIO filing?
The latest filing shown is DEFA14A dated Jun 16, 2026.
How many recent filings does OBIO have?
Intrinsic Alpha currently shows 20 recent filings for OBIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.